Company profile: LifeWatch
1.1 - Company Overview
Company description
- Provider of remote cardiac monitoring and digital health solutions, offering wireless remote diagnostic patient monitoring services that deliver critical data for treatment decisions. Solutions include Philips Mobile Cardiac Telemetry (MCOT), Philips ePatch Extended Holter, Implantable Device Monitoring, EMR Integration, Telehealth Home Connect for at-home monitor application, and Remote INR patient self-testing.
Products and services
- Philips Extended Holter – ePatch: Extended Holter monitoring offering continuous recording for up to 14 days and engineered to deliver comprehensive, actionable reports
- Philips Implantable Device Monitoring: Monitoring service for implantable cardiac devices, supplying continuous data that helps effectively manage patient care
- Philips Mobile Cardiac Telemetry – MCOT: Remote cardiac telemetry that delivers near real-time arrhythmia analysis and high-quality actionable reports to help diagnose and treat arrhythmias quickly
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LifeWatch
Kalila Medical
HQ: United States
Website
- Description: Provider of specialized catheters for vascular and intracardiac access, developing a platform including steerable sheaths for catheter-based atrial fibrillation ablation. Compatible with 8Fr and 12Fr ablation catheters, the Kalila sheath provides superior torque and tip.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kalila Medical company profile →
InterVene
HQ: United States
Website
- Description: Provider of minimally invasive medical devices and therapies for chronic venous disease, particularly deep vein valve failure. The company's BlueLeaf™ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions in the legs, aiming to improve patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InterVene company profile →
Middle Peak Medical
HQ: United States
Website
- Description: Provider of novel medical device technology to treat mitral valve disease, offering a proprietary device applicable to percutaneous catheter-based intervention and minimally invasive or open-heart cardiac surgery, with a focus on development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Middle Peak Medical company profile →
Amarin
HQ: Ireland
Website
- Description: Provider of prescription cardiovascular therapy and clinical research, including VASCEPA/VAZKEPA (icosapent ethyl) to reduce cardiovascular risk in patients with elevated triglycerides and established cardiovascular disease, and the REDUCE-IT global outcomes study evaluating VASCEPA in patients with controlled LDL-C and elevated triglycerides to reduce cardiovascular events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amarin company profile →
HeartIT
HQ: United States
Website
- Description: Provider of medical image viewing and reporting software, offering a browser-based workflow solution that integrates EMR via HL7 messaging and enables image sharing with referring physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartIT company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LifeWatch
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LifeWatch
2.2 - Growth funds investing in similar companies to LifeWatch
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LifeWatch
4.2 - Public trading comparable groups for LifeWatch
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →